Opportunistic Infections Citation List: October 26 - November 8, 2012
ANTIFUNGAL COMPOUNDS (includes Cryptococcus, Aspergillus, Candida, & Histoplasma)
1. Isolation, Characterization and Antifungal Activity of Proteinase Inhibitors from Capsicum chinense Jacq. Seeds. Dias, G.B., V.M. Gomes, U.Z. Pereira, S.F. Ribeiro, A.O. Carvalho, R. Rodrigues, O.L. Machado, K.V. Fernandes, A.T. Ferreira, J. Perales, and M. Da Cunha. The Protein Journal, 2012. [Epub ahead of print]. PMID[23117889].
[PubMed]. OI_1026-110812.
2. Biological Activities of Pseudevernia furfuracea (L.) Zopf Extracts and Isolation of the Active Compounds. Guvenc, A., E.K. Akkol, I. Suntar, H. Keles, S. Yildiz, and I. Calis. Journal of Ethnopharmacology, 2012. [Epub ahead of print]. PMID[23107822].
[PubMed]. OI_1026-110812.
3. Antifungal Susceptibility to Amphotericin B, Fluconazole, Voriconazole, and Flucytosine in Candida Bloodstream Isolates from 15 Tertiary Hospitals in Korea. Jung, S.I., J.H. Shin, H.J. Choi, M.Y. Ju, S.H. Kim, W.G. Lee, Y.J. Park, and K. Lee. Annals of Laboratory Medicine, 2012. 32(6): p. 426-428. PMID[23130342].
[PubMed]. OI_1026-110812.
4. 1-Alkyl-(N,N-dimethylamino)pyridinium bromides: Inhibitory Effect on Virulence Factors of Candida albicans and on the Growth of Bacterial Pathogens. Muthuraman, S., R. Radhakrishnan, V. Perumal, and I. Andivelu. Journal of Medical Microbiology, 2012. [Epub ahead of print]. PMID[23118472].
[PubMed]. OI_1026-110812.
5. Efficacy and Pharmacodynamics of Voriconazole Combined with Anidulafungin in Azole-resistant Invasive Aspergillosis. Seyedmousavi, S., R.J. Bruggemann, W.J. Melchers, A.J. Rijs, P.E. Verweij, and J.W. Mouton. The Journal of Antimicrobial Chemotherapy, 2012. [Epub ahead of print]. PMID[23129729].
[PubMed]. OI_1026-110812.
6. Toxicity, Antimicrobial and Anthelmintic Activities of Vernonia guineensis Benth. (Asteraceae) Crude Extracts. Toyang, N.J., E.N. Ateh, J. Keiser, M. Vargas, H. Bach, P. Tane, L.B. Sondengam, H. Davis, J. Bryant, and R. Verpoorte. Journal of Ethnopharmacology, 2012. [Epub ahead of print]. PMID[23107821].
[PubMed]. OI_1026-110812.
7. Antifungal Effect of Ophthalmic Preservatives Phenylmercuric nitrate and Benzalkonium chloride on Ocular Pathogenic Filamentous Fungi. Xu, Y., Y. He, X. Li, C. Gao, L. Zhou, S. Sun, and G. Pang. Diagnostic Microbiology and Infectious Disease, 2012. [Epub ahead of print]. PMID[23102555]. [PubMed]. OI_1026-110812.
ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)
8. Improving Existing Tools for Mycobacterium xenopi Treatment: Assessment of Drug Combinations and Characterization of Mouse Models of Infection and Chemotherapy. Andrejak, C., D.V. Almeida, S. Tyagi, P.J. Converse, N.C. Ammerman, and J.H. Grosset. The Journal of Antimicrobial Chemotherapy, 2012. [Epub ahead of print]. PMID[23129730].
[PubMed]. OI_1026-110812.
9. Macrolide Treatment for Mycobacterium abscessus and Mycobacterium massiliense Infection and Inducible Resistance. Choi, G.E., S.J. Shin, C.J. Won, K.N. Min, T. Oh, M.Y. Hahn, K. Lee, S.H. Lee, C.L. Daley, S. Kim, B.H. Jeong, K. Jeon, and W.J. Koh. American Journal of Respiratory and Critical Care Medicine, 2012. 186(9): p. 917-925. PMID[22878281].
[PubMed]. OI_1026-110812.
10. Identification and Validation of a Novel Lead Compound Targeting 4-Diphosphocytidyl-2-C-methylerythritol Synthetase (Ispd) of Mycobacteria. Gao, P., Y. Yang, C. Xiao, Y. Liu, M. Gan, Y. Guan, X. Hao, J. Meng, S. Zhou, X. Chen, and J. Cui. European Journal of Pharmacology, 2012. 694(1-3): p. 45-52. PMID[22975264].
[PubMed]. OI_1026-110812.
11. Antimicrobial Peptides from Arachnid venoms and Their Microbicidal Activity in the Presence of Commercial Antibiotics. Garcia, F., E. Villegas, G.P. Espino-Solis, A. Rodriguez, J.F. Paniagua-Solis, G. Sandoval-Lopez, L.D. Possani, and G. Corzo. The Journal of Antibiotics, 2012. [Epub ahead of print]. PMID[23093034].
[PubMed]. OI_1026-110812.
12. Antimycobacterial Assessment of Salicylanilide benzoates Including Multidrug-resistant Tuberculosis Strains. Kratky, M., J. Vinsova, and J. Stolarikova. Molecules, 2012. 17(11): p. 12812-12820. PMID[23114617].
[PubMed]. OI_1026-110812.
13. Synthesis and Evaluation of M. Tuberculosis Salicylate Synthase (Mbti) Inhibitors Designed to Probe Plasticity in the Active Site. Manos-Turvey, A., K.M. Cergol, N.K. Salam, E.M. Bulloch, G. Chi, A. Pang, W.J. Britton, N.P. West, E.N. Baker, J.S. Lott, and R.J. Payne. Organic & Biomolecular Chemistry, 2012. [Epub ahead of print]. PMID[23108268].
[PubMed]. OI_1026-110812.
14. Increment of Antimycobaterial Activity on Lichexanthone Derivatives. Micheletti, A.C., N.K. Honda, F.R. Pavan, C.Q. Leite, M.D. Matos, R.T. Perdomo, D. Bogo, G.B. Alcantara, and A. Beatriz. Medicinal Chemistry (Shariqah (United Arab Emirates)), 2012. [Epub ahead of print]. PMID[23106287].
[PubMed]. OI_1026-110812.
15. 1,3-Azoles from Ortho-naphthoquinones: Synthesis of Aryl Substituted Imidazoles and Oxazoles and Their Potent Activity against Mycobacterium tuberculosis. Moura, K.C., P.F. Carneiro, C. Pinto Mdo, J.A. da Silva, V.R. Malta, C.A. de Simone, G.G. Dias, G.A. Jardim, J. Cantos, T.S. Coelho, P.E. da Silva, and E.N. da Silva, Jr. Bioorganic & Medicinal Chemistry, 2012. 20(21): p. 6482-6488. PMID[23000294].
[PubMed]. OI_1026-110812.
16. In Vitro and in Vivo Antiplasmodial Activity of the Root Extracts of Brucea mollis Wall. ex Kurz. Prakash, A., S.K. Sharma, P.K. Mohapatra, K. Bhattacharjee, K. Gogoi, P. Gogoi, J. Mahanta, and D.R. Bhattacharyya. Parasitology Research, 2012. [Epub ahead of print]. PMID[23108921].
[PubMed]. OI_1026-110812.
17. Evaluation of the Antimycobacterium Activity of the Constituents from Ocimum basilicum against Mycobacterium tuberculosis. Siddiqui, B.S., H.A. Bhatti, S. Begum, and S. Perwaiz. Journal of Ethnopharmacology, 2012. 144(1): p. 220-222. PMID[22982011].
[PubMed]. OI_1026-110812.
18. 6-Hydrogen-8-methylquinolones Active against Replicating and Non-Replicating Mycobacterium tuberculosis. Tabarrini, O., S. Sabatini, S. Massari, M. Pieroni, S.G. Franzblau, and V. Cecchetti. Chemical Biology & Drug Design, 2012. 80(5): p. 781-786. PMID[22889240].
[PubMed]. OI_1026-110812.
ANTIMALARIAL COMPOUNDS (Plasmodium spp.)
19. New Antiplasmodial Alkaloids from Stephania rotunda. Baghdikian, B., V. Mahiou-Leddet, S. Bory, S.S. Bun, A. Dumetre, F. Mabrouki, S. Hutter, N. Azas, and E. Ollivier. Journal of Ethnopharmacology, 2012. [Epub ahead of print]. PMID[23127648].
[PubMed]. OI_1026-110812.
20. 1,4-Naphthoquinones and Others NADPH-Dependent Glutathione Reductase-Catalyzed Redox Cyclers as Antimalarial Agents. Belorgey, D., D.A. Lanfranchi, and E. Davioud-Charvet. Current Pharmaceutical Design, 2012. [Epub ahead of print]. PMID[23116403].
[PubMed]. OI_1026-110812.
21. Incorporation of a 3-(2,2,2-Trifluoroethyl)-gamma-hydroxy-gamma-lactam Motif in the Side Chain of 4-Aminoquinolines. Syntheses and Antimalarial Activities. Cornut, D., H. Lemoine, O. Kanishchev, E. Okada, F. Albrieux, A.H. Beavogui, A.L. Bienvenu, S. Picot, J.P. Bouillon, and M. Medebielle. Journal of Medicinal Chemistry, 2012. [Epub ahead of print]. PMID[23102258].
[PubMed]. OI_1026-110812.
22. 4(1H)-Quinolones with Liver Stage Activity against Plasmodium berghei. Lacrue, A.N., F. Saenz, R.M. Cross, K.O. Udenze, A. Monastyrskyi, S. Stein, T.S. Mutka, R. Manetsch, and D.E. Kyle. Antimicrobial Agents and Chemotherapy, 2012. [Epub ahead of print]. PMID[23129047].
[PubMed]. OI_1026-110812.
23. Pyrido[1,2-a]pyrimidin-4-ones as Antiplasmodial Falcipain-2 Inhibitors. Mane, U.R., H. Li, J. Huang, R.C. Gupta, S.S. Nadkarni, R. Giridhar, P.P. Naik, and M.R. Yadav. Bioorganic & Medicinal Chemistry, 2012. 20(21): p. 6296-6304. PMID[23040894].
[PubMed]. OI_1026-110812.
ANTIPROTOZOAL COMPOUNDS
24. Toxoplasma gondii: Effects of Exogenous Nitric Oxide on Egress of Tachyzoites from Infected Macrophages. Ji, Y.S., X.M. Sun, X.Y. Liu, and X. Suo. Experimental Parasitology, 2012. [Epub ahead of print]. PMID[23110858].
[PubMed]. OI_1026-110812.
Citations from the ISI Web of Knowledge Listings for O.I.
25. Facile Synthesis of Novel Fluorine Containing Pyrazole Based Thiazole Derivatives and Evaluation of Antimicrobial Activity. Desai, N.C., V.V. Joshi, K.M. Rajpara, H.V. Vaghani, and H.M. Satodiya. Journal of Fluorine Chemistry, 2012. 142: p. 67-78. ISI[000308621800010].
[WOS]. OI_1026-110812.
26. 17-Allylamino-17-(demethoxy)geldanamycin (17-AAG) Is a Potent and Effective Inhibitor of Human Cytomegalovirus Replication in Primary Fibroblast Cells. Evers, D.L., C.F. Chao, Z.G. Zhang, and E.S. Huang. Archives of Virology, 2012. 157(10): p. 1971-1974. ISI[000309234500012].
[WOS]. OI_1026-110812.
27. Antimicrobial Activity of a Biosurfactant Produced by Bacillus licheniformis Strain M104 Grown on Whey. Gomaa, E.Z. African Journal of Microbiology Research, 2012. 6(20): p. 4396-4403. ISI[000307405500028].
[WOS]. OI_1026-110812.
28. Application of Fragment Screening and Merging to the Discovery of Inhibitors of the Mycobacterium tuberculosis Cytochrome P450 Cyp121. Hudson, S.A., K.J. McLean, S. Surade, Y.Q. Yang, D. Leys, A. Ciulli, A.W. Munro, and C. Abell. Angewandte Chemie-International Edition, 2012. 51(37): p. 9311-9316. ISI[000308399500018].
[WOS]. OI_1026-110812.
29. Microwave Synthesis and Spectral, Thermal and Antimicrobial Activities of Some Novel Transition Metal Complexes with Tridentate Schiff Base Ligands. Jain, R.K. and A.P. Mishra. Journal of the Serbian Chemical Society, 2012. 77(8): p. 1013-1029. ISI[000308830900004].
[WOS]. OI_1026-110812.
30. Leishmanicidal and Anticandidal Activity of Constituents of Indian Edible Mushroom Astraeus hygrometricus. Lai, T.K., G. Biswas, S. Chatterjee, A. Dutta, C. Pal, J. Banerji, N. Bhuvanesh, J.H. Reibenspies, and K. Acharya. Chemistry & Biodiversity, 2012. 9(8): p. 1517-1524. ISI[000307773700012].
[WOS]. OI_1026-110812.
31. Synthesis, Structure Optimization and Antifungal Screening of Novel Tetrazole Ring Bearing Acyl-Hydrazones. Malik, M.A. and S.A. Al-Thabaiti. International Journal of Molecular Sciences, 2012. 13(9): p. 10880-10898. ISI[000309272700012].
[WOS]. OI_1026-110812.
32. Anti-candidal Activity of Astragalus verus in the in Vitro and in Vivo Guinea Pig Models of Cutaneous and Systemic Candidiasis. Mikaeili, A., I. Karimi, T. Shamspur, B. Gholamine, M. Modaresi, and A. Khanlari. Revista Brasileira De Farmacognosia-Brazilian Journal of Pharmacognosy, 2012. 22(5): p. 1035-1043. ISI[000308948000014].
[WOS]. OI_1026-110812.
33. Indole, a Bacterial Signaling Molecule, Exhibits Inhibitory Activity against Growth, Dimorphism and Biofilm Formation in Candida albicans. Raut, J.S., R.B. Shinde, and M.S. Karuppayil. African Journal of Microbiology Research, 2012. 6(30): p. 6005-6012. ISI[000308916000016].
[WOS]. OI_1026-110812.
34. Synthesis of Eperezolid-Like Molecules and Evaluation of Their Antimicrobial Activities. Yolal, M., S. Basoglu, H. Bektas, S. Demirci, S. Alpay-Karaoglu, and A. Demirbas. Russian Journal of Bioorganic Chemistry, 2012. 38(5): p. 539-549. ISI[000308820300011].
[WOS]. OI_1026-110812.